Dose-related physostigmine-induced ventricular arrhythmia: Case report

Maurice W Dysken, D. S. Janowsky

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Physostigmine, a centrally-acting cholinesterase inhibitor, has been shown to have potential as a treatment for primary degenerative dementia. In an experiment to test its effects, i.v. physostigmine caused the onset of unifocal premature contractions and runs of bigeminy in an 85-year-old man.

Original languageEnglish (US)
Pages (from-to)446-447
Number of pages2
JournalJournal of Clinical Psychiatry
Issue number10
StatePublished - Dec 1 1985


Dive into the research topics of 'Dose-related physostigmine-induced ventricular arrhythmia: Case report'. Together they form a unique fingerprint.

Cite this